Optimization of the native glucagon sequence for medicinal purposes von Chabenne, Joseph R, DiMarchi, Maria A, Gelfanov, Vasily M, DiMarchi, Richard D

Volltext

129: Diagnosing Fetal Alcohol Spectrum Disorder, the Need for Genetic Testing: A Pilot Study von Stade, BC, Watson, W, Bonifacio, J, McCleod, HJ, Barozzino, T, DiMarchi, A, Becker, B, Bartholomew, L, Sgro, M

Volltext

Fibroblast growth factor 21 night watch: advances and uncertainties in the field von Kharitonenkov, A., DiMarchi, R.

Volltext

Anti-obesity drug discovery: advances and challenges von Müller, Timo D., Blüher, Matthias, Tschöp, Matthias H., DiMarchi, Richard D.

Volltext

FGF21 Revolutions: Recent Advances Illuminating FGF21 Biology and Medicinal Properties von Kharitonenkov, Alexei, DiMarchi, Richard

Volltext

Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety von He, Rongjun, Finan, Brian, Mayer, John P, DiMarchi, Richard D

Volltext

The New Biology and Pharmacology of Glucagon von Müller, T D, Finan, B, Clemmensen, C, DiMarchi, R D, Tschöp, M H

Volltext

Anti-Obesity Therapy: from Rainbow Pills to Polyagonists von Müller, T D, Clemmensen, C, Finan, B, DiMarchi, R D, Tschöp, M H

Volltext

Unimolecular Polypharmacy for Treatment of Diabetes and Obesity von Tschöp, Matthias H., Finan, Brian, Clemmensen, Christoffer, Gelfanov, Vasily, Perez-Tilve, Diego, Müller, Timo D., DiMarchi, Richard D.

Volltext

Pursuit of a perfect insulin von Zaykov, Alexander N., Mayer, John P., DiMarchi, Richard D.

Volltext

Glucagon-like peptide 1 (GLP-1) von Müller, T.D., Finan, B., Bloom, S.R., D'Alessio, D., Drucker, D.J., Flatt, P.R., Fritsche, A., Gribble, F., Grill, H.J., Habener, J.F., Holst, J.J., Langhans, W., Meier, J.J., Nauck, M.A., Perez-Tilve, D., Pocai, A., Reimann, F., Sandoval, D.A., Schwartz, T.W., Seeley, R.J., Stemmer, K., Tang-Christensen, M., Woods, S.C., DiMarchi, R.D., Tschöp, M.H.

Volltext

A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents von Finan, Brian, Yang, Bin, Ottaway, Nickki, Smiley, David L, Ma, Tao, Clemmensen, Christoffer, Chabenne, Joe, Zhang, Lianshan, Habegger, Kirk M, Fischer, Katrin, Campbell, Jonathan E, Sandoval, Darleen, Seeley, Randy J, Bleicher, Konrad, Uhles, Sabine, Riboulet, William, Funk, Jürgen, Hertel, Cornelia, Belli, Sara, Sebokova, Elena, Conde-Knape, Karin, Konkar, Anish, Drucker, Daniel J, Gelfanov, Vasily, Pfluger, Paul T, Müller, Timo D, Perez-Tilve, Diego, DiMarchi, Richard D, Tschöp, Matthias H

Volltext

Reappraisal of GIP Pharmacology for Metabolic Diseases von Finan, Brian, Müller, Timo D, Clemmensen, Christoffer, Perez-Tilve, Diego, DiMarchi, Richard D, Tschöp, Matthias H

Volltext

The Sustained Effects of a Dual GIP/GLP-1 Receptor Agonist, NNC0090-2746, in Patients with Type 2 Diabetes von Frias, Juan Pablo, Bastyr, Edward J., Vignati, Louis, Tschöp, Matthias H., Schmitt, Christophe, Owen, Klara, Christensen, Rune Haubo, DiMarchi, Richard D.

Volltext

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism von Mroz, Piotr A., Finan, Brian, Gelfanov, Vasily, Yang, Bin, Tschöp, Matthias H., DiMarchi, Richard D., Perez-Tilve, Diego

Volltext

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes von Tan, Qiming, Akindehin, Seun E, Orsso, Camila E, Waldner, Richelle C, DiMarchi, Richard D, Müller, Timo D, Haqq, Andrea M

Volltext

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes von Capozzi, Megan E, DiMarchi, Richard D, Tschöp, Matthias H, Finan, Brian, Campbell, Jonathan E

Volltext

Zn-regulated GTPase metalloprotein activator 1 modulates vertebrate zinc homeostasis von Weiss, Andy, Murdoch, Caitlin C., Edmonds, Katherine A., Jordan, Matthew R., Monteith, Andrew J., Perera, Yasiru R., Rodríguez Nassif, Aslin M., Petoletti, Amber M., Beavers, William N., Munneke, Matthew J., Drury, Sydney L., Krystofiak, Evan S., Thalluri, Kishore, Wu, Hongwei, Kruse, Angela R.S., DiMarchi, Richard D., Caprioli, Richard M., Spraggins, Jeffrey M., Chazin, Walter J., Giedroc, David P., Skaar, Eric P.

Volltext

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications von Campbell, Jonathan E, Müller, Timo D, Finan, Brian, DiMarchi, Richard D, Tschöp, Matthias H, D'Alessio, David A

Volltext

Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice von Knerr, Patrick J., Mowery, Stephanie A., Douros, Jonathan D., Premdjee, Bhavesh, Hjøllund, Karina Rahr, He, Yantao, Kruse Hansen, Ann Maria, Olsen, Anette K., Perez-Tilve, Diego, DiMarchi, Richard D., Finan, Brian

Volltext